Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.

Neuropathology and applied neurobiology - 1 Feb 2021

Petersen J K, Boldt H B, Sørensen M D, Blach S, Dahlrot R H, Hansen S, Burton M, Thomassen M, Kruse T, Poulsen F R, Andreasen L, Hager H, Ulhøi B P, Lukacova S, Reifenberger G, Kristensen B W

Abstract excerpt

AIMS: We aimed to reclassify a population-based cohort of 529 adult glioma patients to evaluate the prognostic impact of the 2016 World Health Organization (WHO) central nervous system tumour classification. Moreover, we evaluated the feasibility of gene panel next-generation sequencing (NGS) in daily diagnostics of 225 prospective glioma patients. METHODS: The retrospective cohort was reclassified according to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Glioblastoma

Share to Glioma

Share to High-Throughput Nucleotide Sequencing

Share to Isocitrate Dehydrogenase

Share to Telomerase

Source

Identifiers

PMID: 32696543
DOI: 10.1111/nan.12645

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.PMID 32696543Read ↗

Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel.Semantic proximity Read ↗

A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomasSemantic proximity Read ↗

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsSemantic proximity Read ↗

miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targetsSemantic proximity Read ↗

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors.Semantic proximity Read ↗

Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.Semantic proximity Read ↗

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.Semantic proximity Read ↗

Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in GliomasSemantic proximity Read ↗

Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.Semantic proximity Read ↗

Molecular Landscape and Contemporary Prognostic Signatures of GliomasSemantic proximity Read ↗

Molecular profiling of CNS tumors for the treatment and management of disease.Semantic proximity Read ↗

Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.